The growing demand for specific immunological investigation and therapeutic design has spurred significant advances in recombinant growth factor generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently generated using diverse expression systems, including prokaryotic hosts, animal cell lines, and baculovirus